Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-25-093102

Options or other derivatives

  • Director acquired 21,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ajer Jeffrey Robert Director 2025-07-01 Grant or award · Stock Option (Right to Buy) +21,000 21,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…